165 related articles for article (PubMed ID: 10545704)
1. Clinical implications of genetic testing of hereditary nonpolyposis colorectal cancer.
Vasen HF; Wijnen J
Cytogenet Cell Genet; 1999; 86(2):136-9. PubMed ID: 10545704
[No Abstract] [Full Text] [Related]
2. Identifying hereditary nonpolyposis colorectal cancer.
Lynch HT; Smyrk TC
N Engl J Med; 1998 May; 338(21):1537-8. PubMed ID: 9593794
[No Abstract] [Full Text] [Related]
3. Multimodal molecular screening is required to improve the sensitivity of MLH1 and MSH2 mutation analysis.
Andermann A; Thiffault I; Wong N; Gordon P; MacNamara E; Chong G; Foulkes W
J Clin Oncol; 2002 Mar; 20(6):1705-7. PubMed ID: 11896123
[No Abstract] [Full Text] [Related]
4. Genetic testing in hereditary non-polyposis colorectal cancer families with a MSH2, MLH1, or MSH6 mutation.
Wagner A; Tops C; Wijnen JT; Zwinderman K; van der Meer C; Kets M; Niermeijer MF; Klijn JG; Tibben A; Vasen HF; Meijers-Heijboer H
J Med Genet; 2002 Nov; 39(11):833-7. PubMed ID: 12414824
[No Abstract] [Full Text] [Related]
5. Molecular diagnosis of hereditary nonpolyposis colorectal cancer.
O'Leary TJ
JAMA; 1999 Jul; 282(3):281-2. PubMed ID: 10422999
[No Abstract] [Full Text] [Related]
6. HNPCC: an uncommon but important diagnosis.
Terdiman JP
Gastroenterology; 2001 Oct; 121(4):1005-8. PubMed ID: 11606514
[No Abstract] [Full Text] [Related]
7. Incidence of germline hMLH1 and hMSH2 mutations (HNPCC patients) among newly diagnosed colorectal cancers in a Slovenian population.
Ravnik-Glavac M; Potocnik U; Glavac D
J Med Genet; 2000 Jul; 37(7):533-6. PubMed ID: 10970186
[No Abstract] [Full Text] [Related]
8. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease.
Aaltonen LA; Salovaara R; Kristo P; Canzian F; Hemminki A; Peltomäki P; Chadwick RB; Kääriäinen H; Eskelinen M; Järvinen H; Mecklin JP; de la Chapelle A
N Engl J Med; 1998 May; 338(21):1481-7. PubMed ID: 9593786
[TBL] [Abstract][Full Text] [Related]
9. [Hereditary nonpolyposis colorectal cancer].
Matsukawa M; Yamamoto T; Kouda T
Nihon Rinsho; 2003 Sep; 61 Suppl 7():189-92. PubMed ID: 14574879
[No Abstract] [Full Text] [Related]
10. Re: Characterization of hereditary nonpolyposis colorectal cancer families from a population-based series of cases.
Evans DG; Wu CL; Walsh S; Hansen I; Verma L; Robinson C; Kingston R; Maher ER
J Natl Cancer Inst; 2001 May; 93(9):716-7. PubMed ID: 11333295
[No Abstract] [Full Text] [Related]
11. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer.
Wijnen JT; Vasen HF; Khan PM; Zwinderman AH; van der Klift H; Mulder A; Tops C; Møller P; Fodde R
N Engl J Med; 1998 Aug; 339(8):511-8. PubMed ID: 9709044
[TBL] [Abstract][Full Text] [Related]
12. Novel splicing associations of hereditary colon cancer related DNA mismatch repair gene mutations.
Renkonen E; Lohi H; Järvinen HJ; Mecklin JP; Peltomäki P
J Med Genet; 2004 Jul; 41(7):e95. PubMed ID: 15235038
[No Abstract] [Full Text] [Related]
13. Genetic testing for hereditary nonpolyposis colorectal cancer.
Hoedema R; Monroe T; Bos C; Palmer S; Kim D; Marvin M; Luchtefeld M
Am Surg; 2003 May; 69(5):387-91; discussion 391-2. PubMed ID: 12769209
[TBL] [Abstract][Full Text] [Related]
14. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium.
Plaschke J; Engel C; Krüger S; Holinski-Feder E; Pagenstecher C; Mangold E; Moeslein G; Schulmann K; Gebert J; von Knebel Doeberitz M; Rüschoff J; Loeffler M; Schackert HK
J Clin Oncol; 2004 Nov; 22(22):4486-94. PubMed ID: 15483016
[TBL] [Abstract][Full Text] [Related]
15. [Clinical features and hMSH2/hMLH1 germline mutation screening of Chinese hereditary nonpolyposis colorectal cancer patients].
Liu SR; Wang ZJ; Zhao B; Wan YL; Huang YT
Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):714-7. PubMed ID: 15200905
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and management of hereditary non-polyposis colon cancer.
DeFrancisco J; Grady WM
Gastrointest Endosc; 2003 Sep; 58(3):390-408. PubMed ID: 14528214
[No Abstract] [Full Text] [Related]
17. Mutational germline analysis of hMSH2 and hMLH1 genes in early onset colorectal cancer patients.
Montera M; Resta N; Simone C; Guanti G; Marchese C; Civitelli S; Mancini A; Pozzi S; De Salvo L; Bruzzone D; Donadini A; Romio L; Mareni C
J Med Genet; 2000 Jul; 37(7):E7. PubMed ID: 10882759
[No Abstract] [Full Text] [Related]
18. Spectrum of genetic alterations in Muir-Torre syndrome is the same as in HNPCC.
Barana D; van der Klift H; Wijnen J; Longa ED; Radice P; Cetto GL; Fodde R; Oliani C
Am J Med Genet A; 2004 Mar; 125A(3):318-9. PubMed ID: 14994245
[No Abstract] [Full Text] [Related]
19. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer.
Piñol V; Castells A; Andreu M; Castellví-Bel S; Alenda C; Llor X; Xicola RM; Rodríguez-Moranta F; Payá A; Jover R; Bessa X;
JAMA; 2005 Apr; 293(16):1986-94. PubMed ID: 15855432
[TBL] [Abstract][Full Text] [Related]
20. Germline and somatic mutation analyses in the DNA mismatch repair gene MLH3: Evidence for somatic mutation in colorectal cancers.
Lipkin SM; Wang V; Stoler DL; Anderson GR; Kirsch I; Hadley D; Lynch HT; Collins FS
Hum Mutat; 2001 May; 17(5):389-96. PubMed ID: 11317354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
